Deutsche Bank Raises Medco (MHS) to Buy; Says Overhangs Removed
Tweet
Share
E-mailGet Alerts MHS Hot Sheet
Price: $70.30 --0%
Rating Summary:
5 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Deutsche Bank upgraded shares of Medco Health Solutions (NYSE: MHS) from Hold to Buy in late-session trade Wednesday following the company's Q3 results and raised guidance this morning. The analyst boosted his price target from $56 to $60.
Analysts Ross Muken and Michael Cherny cite "increased comfort with deal closure and marginalized downside risk post recent guidance / contract loss disclosures..." The analysts see a standalone stock value of $47 per share if a deal does not go through.
For more ratings news on Medco Health Solutions click here and for the rating history of Medco Health Solutions click here.
Analysts Ross Muken and Michael Cherny cite "increased comfort with deal closure and marginalized downside risk post recent guidance / contract loss disclosures..." The analysts see a standalone stock value of $47 per share if a deal does not go through.
For more ratings news on Medco Health Solutions click here and for the rating history of Medco Health Solutions click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Deutsche Bank, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
